These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 23095422

  • 21. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J, Wigal SB, Spencer TJ, McGough JJ, Mays DA.
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [Abstract] [Full Text] [Related]

  • 22. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Palli SR, Kamble PS, Chen H, Aparasu RR.
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
    [Abstract] [Full Text] [Related]

  • 23. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.
    Kaplan G, Newcorn JH.
    Pediatr Clin North Am; 2011 Feb; 58(1):99-120, xi. PubMed ID: 21281851
    [Abstract] [Full Text] [Related]

  • 24. A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD).
    Pohl GM, Van Brunt DL, Ye W, Stoops WW, Johnston JA.
    BMC Health Serv Res; 2009 Jun 08; 9():95. PubMed ID: 19505334
    [Abstract] [Full Text] [Related]

  • 25. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
    Niederkirchner K, Slawik L, Wermelskirchen D, Rettig K, Schäuble B.
    Expert Rev Neurother; 2011 Apr 08; 11(4):499-508. PubMed ID: 21469923
    [Abstract] [Full Text] [Related]

  • 26. Decreased use of clonidine following treatment with atomoxetine in children with ADHD.
    Johnston JA, Ye W, Van Brunt DL, Pohl G, Sumner CR.
    J Clin Psychopharmacol; 2006 Aug 08; 26(4):389-95. PubMed ID: 16855457
    [Abstract] [Full Text] [Related]

  • 27. Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.
    Wigal SB, Chae S, Patel A, Steinberg-Epstein R.
    Semin Pediatr Neurol; 2010 Dec 08; 17(4):230-6. PubMed ID: 21183129
    [Abstract] [Full Text] [Related]

  • 28. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
    Sallee FR.
    Postgrad Med; 2010 Sep 08; 122(5):78-87. PubMed ID: 20861591
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications.
    McAfee AT, Landon J, Jones M, Bangs ME, Acharya N, Hornbuckle K, Wong J.
    Pharmacoepidemiol Drug Saf; 2013 Apr 08; 22(4):386-93. PubMed ID: 23280590
    [Abstract] [Full Text] [Related]

  • 33. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Jerrell JM, McIntyre RS, Park YM.
    J Clin Psychiatry; 2014 Nov 08; 75(11):e1278-83. PubMed ID: 25470092
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
    Brinker A, Mosholder A, Schech SD, Burgess M, Avigan M.
    J Child Adolesc Psychopharmacol; 2007 Jun 08; 17(3):328-33. PubMed ID: 17630866
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
    Davis DW, Feygin Y, Creel L, Kong M, Jawad K, Sun J, Blum NJ, Lohr WD, Williams PG, Le J, Jones VF, Pasquenza N.
    J Child Adolesc Psychopharmacol; 2020 Sep 08; 30(7):448-455. PubMed ID: 32614247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.